Natural Beauty Bio-Technology Limited
Símbolo: 0157.HK
HKSE
0.51
HKDPrecio de mercado actual
-67.5714
Ratio PER
-2.4025
Ratio PEG
1.02B
Capitalización MRK
- 0.00%
Rendimiento DIV
Natural Beauty Bio-Technology Limited (0157-HK) Estados Financieros
Balance de situación
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 166.8 | 168.6 | 197.1 | |||||||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 8.1 | 8 | 8.9 | |||||||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 85.4 | 80.9 | 119.9 | |||||||||||||||||||||||
balance-sheet.row.inventory | 0 | 77.6 | 98.8 | 121 | |||||||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 13.3 | 16.3 | 12.1 | |||||||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 343 | 364.6 | 450 | |||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 270.6 | 238.4 | 417.1 | |||||||||||||||||||||||
balance-sheet.row.goodwill | 0 | 25.2 | 25.7 | 29.6 | |||||||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 25.7 | 35.3 | |||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 25.2 | 51.4 | 64.9 | |||||||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 217.7 | 228.7 | 9.5 | |||||||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 24.4 | 25.2 | 25 | |||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 1.6 | -24.7 | -29.3 | |||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 539.5 | 518.9 | 487.1 | |||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.total-assets | 0 | 882.6 | 883.5 | 937.2 | |||||||||||||||||||||||
balance-sheet.row.account-payables | 0 | 20.7 | 9.8 | 15.2 | |||||||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 171.7 | 119.4 | 94.8 | |||||||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 3 | 7.5 | 19.3 | |||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 3.5 | 6 | 9.5 | |||||||||||||||||||||||
Deferred Revenue Non Current | 0 | 0 | 24.1 | 24.8 | |||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 71.2 | 104.8 | 114.4 | |||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 24.7 | 35.3 | 41.3 | |||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 11.1 | 18 | 24.8 | |||||||||||||||||||||||
balance-sheet.row.total-liab | 0 | 308.1 | 286.1 | 279.2 | |||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.common-stock | 0 | 200.2 | 200.2 | 200.2 | |||||||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | 39.1 | 54.6 | 85.4 | |||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 263.6 | 271.1 | 294.7 | |||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 71.6 | 71.6 | 77.6 | |||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 574.5 | 597.5 | 657.9 | |||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 882.6 | 883.5 | 937.2 | |||||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.total-equity | 0 | 574.5 | 597.5 | 657.9 | |||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||||||||||||
Total Investments | 0 | 225.8 | 236.7 | 18.4 | |||||||||||||||||||||||
balance-sheet.row.total-debt | 0 | 186.3 | 143.5 | 129.1 | |||||||||||||||||||||||
balance-sheet.row.net-debt | 0 | 27.5 | -17.1 | -59.1 |
Estado de tesorería
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -15.1 | -30.5 | 35.3 | |||||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 26.6 | 34.3 | 35 | |||||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | 4.4 | -0.1 | -35.8 | |||||||||||||||||||||||
cash-flows.row.account-receivables | 0 | 1 | 19.7 | 6.7 | |||||||||||||||||||||||
cash-flows.row.inventory | 0 | 16.5 | -1 | -27 | |||||||||||||||||||||||
cash-flows.row.account-payables | 0 | -16.1 | -23.3 | -16.6 | |||||||||||||||||||||||
cash-flows.row.other-working-capital | 0 | 3 | 4.4 | 1 | |||||||||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 0.3 | 4.6 | 8.4 | |||||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -69.1 | -44.3 | -38.1 | |||||||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0.3 | 8.2 | |||||||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | -1.3 | |||||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | -9 | |||||||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 9 | |||||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -69.1 | -44 | -31.2 | |||||||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -54.3 | -31.2 | -27.2 | |||||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | -6 | -6 | |||||||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | 104 | 55.3 | 47.6 | |||||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 49.6 | 18.1 | 14.3 | |||||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 1.4 | -9.9 | 4.1 | |||||||||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | -1.8 | -27.6 | 30.1 | |||||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 158.7 | 160.6 | 188.2 | |||||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 160.6 | 188.2 | 158.2 | |||||||||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 16.2 | 8.3 | 42.8 | |||||||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -69.1 | -44.3 | -38.1 | |||||||||||||||||||||||
cash-flows.row.free-cash-flow | 0 | -52.9 | -36 | 4.7 |
Fila de la Cuenta de Resultados
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 336 | 335.9 | 487.8 | |||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 157.3 | 170.6 | 206 | |||||||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 178.7 | 165.3 | 281.8 | |||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.other-expenses | 0 | 5.8 | 7 | 4.5 | |||||||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 182.5 | 188.7 | 237 | |||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 339.8 | 359.3 | 443.1 | |||||||||||||||||||||||
income-statement-row.row.interest-income | 0 | 1.5 | 1.7 | 2.1 | |||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 8.1 | 6.2 | 4.9 | |||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -8.1 | -0.1 | 3.7 | |||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 5.8 | 7 | 4.5 | |||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -8.1 | -0.1 | 3.7 | |||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 8.1 | 6.2 | 4.9 | |||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 26.6 | 34.3 | 35 | |||||||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.operating-income | 0 | -3.8 | -23.4 | 44.7 | |||||||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | -11.9 | -23.5 | 48.5 | |||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 3.2 | 6.9 | 13.2 | |||||||||||||||||||||||
income-statement-row.row.net-income | 0 | -15.1 | -30.5 | 35.3 |
Preguntas frecuentes
Cuánto es Natural Beauty Bio-Technology Limited (0157.HK) activos totales?
Natural Beauty Bio-Technology Limited (0157.HK) los activos totales son 882583000.000.
¿Cuáles son los ingresos anuales de la empresa?
Los ingresos anuales son N/A.
¿Cuál es el margen de beneficios de la empresa?
El margen de beneficios de la empresa es 0.532.
¿Qué es el flujo de caja libre de la empresa?
El flujo de caja libre es -0.026.
¿Cuál es el margen de beneficio neto de la empresa?
El margen de beneficio neto es -0.045.
¿Cuáles son los ingresos totales de la empresa?
Los ingresos totales son -0.011.
¿Qué es Natural Beauty Bio-Technology Limited (0157.HK) beneficio neto (ingresos netos)?
El beneficio neto (ingresos netos) es -15111000.000.
¿Cuál es la deuda total de la empresa?
La deuda total es 186287000.000.
¿Cuál es la cifra de gastos de explotación?
Los gastos de explotación son 182497000.000.
¿Cuál es la cifra de tesorería de la empresa?
La tesorería de la empresa es 0.000.